Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Volans, Andrew ^a   Ferguson, Robert ^a  

^a SCARBOROUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CHLORPHENIRAMINE; COMPLEMENT COMPONENT C1S; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; NICORANDIL; RAMIPRIL; STEROID; TRANEXAMIC ACID;

AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; ENDOSCOPY; FEMALE; HORMONAL THERAPY; HUMAN; HYPERSALIVATION; LARYNGOSCOPY; LARYNX STENOSIS; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; SPEECH DISORDER; TACHYCARDIA; THORAX PAIN; TONGUE SWELLING; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 84874718606     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-008295     Document Type: Article

References (13)

1. Thiagarajan J, Chris H, Anthony W. Bethune hereditary angioedema: a survey of UK emergency departments and recommendations for management. Claire Eur J Emerg Med. 2012;19:271-4.
2. Joseph J, Moellman MD, Jonathan A, et al. Diagnosis and management of hereditary angioedema: an emergency medicine perspective. J Emerg Med 2012;43:391-400.
3. Konrad Bork MD, Frank J, Grundt B. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allerg Clin Immunol 2007;119:1497-503.
4. Fryer RM, Segreti J, Banfor PN, et al. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema. Br J Pharmacol 2008;153:947-55.
5. Binkley K. Factor XII mutations, estrogen-dependent inherited angioedema and related conditions. Allerg Asthma Clin Immunol 2012;6:16.
6. Murray A, Crowther J. ACE inhibitor use and severe angioedema. Postgrad Med J 1998;74:571-2.
7. Longhurst HJ. Management of hereditary angioedema: potential role of icatibant. Vasc Health Risk Manag 2010;6:795-802.
8. Kaplan A, Kusumam J. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol 2010;104:193-204.
9. Bowen T, Brosz K, Brosz J, et al. Management of hereditary angioedema: 2010 Canadian approach. Allerg Asthma Clin Immunol 2010;6:20.
10. Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 2010;56:278-82.
11. Nussberger J, Cugno M, Cicardi M. Local bradykinin generation in hereditary angioedema jürg nussberger. J Allergy Clin Immunol 1999;104:1321-2.
12. Cicardi M, Banerji A, Braco F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532-41.
13. Cicardi M, Bork K, Caballero T, et al. on behalf of HAWK (Hereditary Angioedema International Working Group) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012;67:147-57.